View Older Stories

Apr 1, 2026 08:04AM Quantum BioPharma submits IND application to FDA for MS drug trial

Mar 27, 2026 08:11AM Quantum BioPharma reports $11.3 million cash runway through January 2028

Dec 23, 2025 08:02AM Quantum BioPharma completes dosing in toxicity studies for MS drug

Dec 22, 2025 09:00AM World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Dec 10, 2025 08:02PM Quantum BioPharma closes $750 private placement, terminates ATM agreement

Dec 10, 2025 08:00PM Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Oct 29, 2025 09:00PM Quantum BioPharma Ltd. Announces Corporate Updates

Oct 20, 2025 08:31AM Quantum BioPharma warrants expire, confirms CVR record date

Oct 14, 2025 08:15AM Quantum BioPharma disputes law firm securities investigation claims

Oct 8, 2025 08:03AM Quantum BioPharma offers $7 million reward for stock manipulation proof

Oct 7, 2025 11:01AM Quantum BioPharma gets dual listing on Upstream digital exchange

Oct 7, 2025 11:00AM Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 3, 2025 07:01AM Quantum BioPharma sets record date for litigation-linked dividend rights

Oct 1, 2025 07:50AM Quantum BioPharma adds multiple sclerosis expert as clinical advisor

Sep 29, 2025 07:44AM Quantum BioPharma shareholders approve board nominees and auditor

Sep 28, 2025 11:28AM Quantum BioPharma grants stock options and restricted share units

Sep 26, 2025 08:00PM Quantum BioPharma Announces Corporate Updates

Sep 18, 2025 08:10AM Quantum BioPharma receives Health Canada license for Qlarity supplement

Aug 11, 2025 06:34PM Quantum BioPharma seeks shareholder approval for $600 private placement

Aug 11, 2025 06:32PM Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 8, 2025 08:01AM Quantum BioPharma reports progress on PET tracer for multiple sclerosis

Aug 7, 2025 07:01AM Quantum BioPharma reports Q2 gains with debt conversion to equity

Aug 4, 2025 07:33AM Quantum BioPharma files court response in $700 million lawsuit against banks

Jul 22, 2025 08:52AM Quantum BioPharma invests in 2,000 GameStop shares

Jul 8, 2025 08:11AM Quantum BioPharma (QNTM) submits multiple sclerosis drug to UK fast-track program

Jun 27, 2025 04:30PM Quantum BioPharma (QNTM) Announces Private Placement

Jun 26, 2025 07:30AM Quantum BioPharma (QNTM) Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025 09:19AM Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025 08:00AM Quantum BioPharma (QNTM) Announces First Person with Multiple Sclerosis Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025 07:01AM Quantum BioPharma (QNTM) to Declare Special Dividend of Contingent Value Rights Linked to Future Litigation Settlement Proceeds

Jun 10, 2025 08:00AM Quantum BioPharma (QNTM) Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000

Jun 3, 2025 07:50AM Quantum BioPharma (QNTM) Clarifies It Has Not Changed Its Name

May 30, 2025 07:00AM Quantum BioPharma (QNTM) Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025 07:31AM Quantum BioPharma (QNTM) Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025 08:00AM Quantum BioPharma (QNTM) Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202

May 21, 2025 08:06AM Quantum BioPharma (QNTM) Partners with BitGo to Securely Store its Crypto Currency Assets

May 20, 2025 07:31AM Quantum BioPharma (QNTM) Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND

May 19, 2025 07:30AM Quantum BioPharma (QNTM) Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies

May 12, 2025 08:04AM Quantum BioPharma (QNTM) Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

Apr 22, 2025 07:00AM Quantum BioPharma (QNTM) Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Apr 18, 2025 08:00PM Quantum BioPharma Corporate Update

Apr 14, 2025 07:30AM Quantum BioPharma (QNTM) Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario

Apr 10, 2025 07:30AM Quantum BioPharma (QNTM) Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council

Apr 3, 2025 07:01AM Quantum BioPharma (QNTM) Licensee Celly Nutrition Launches unbuzzd in Puerto Rico

Mar 31, 2025 07:03AM Quantum BioPharma (QNTM) Closes $2.42M Tranche of $5M Total Financing on Improved Terms

Mar 30, 2025 07:00PM Quantum BioPharma Provides Corporate Update

Mar 28, 2025 09:16AM Quantum BioPharma (QNTM) Reports Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Mar 28, 2025 09:15AM Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Mar 27, 2025 07:00AM Quantum BioPharma (QNTM) Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors

Mar 20, 2025 07:30AM Quantum BioPharma (QNTM) Buys Another $1,500,000 Worth of Bitcoin and Other Cryptocurrencies

View Older Stories